Back to Search Start Over

Selection of adjuvants for vaccines targeting specific pathogens

Authors :
Ravendra Garg
Indranil Sarkar
Sylvia van Drunen Littel-van den Hurk
Source :
Expert Review of Vaccines
Publication Year :
2019
Publisher :
Taylor & Francis, 2019.

Abstract

Introduction: Adjuvants form an integral component in most of the inactivated and subunit vaccine formulations. Careful and proper selection of adjuvants helps in promoting appropriate immune responses against target pathogens at both innate and adaptive levels such that protective immunity can be elicited. Areas covered: Herein, we describe the recent progress in our understanding of the mode of action of adjuvants that are licensed for use in human vaccines or in clinical or pre-clinical stages at both innate and adaptive levels. Different pathogens have distinct characteristics, which require the host to mount an appropriate immune response against them. Adjuvants can be selected to elicit a tailor-made immune response to specific pathogens based on their unique properties. Identification of biomarkers of adjuvanticity for several candidate vaccines using omics-based technologies can unravel the mechanism of action of modern and experimental adjuvants. Expert opinion: Adjuvant technology has been revolutionized over the last two decades. In-depth understanding of the role of adjuvants in activating the innate immune system, combined with systems vaccinology approaches, have led to the development of next-generation, novel adjuvants that can be used in vaccines against challenging pathogens and in specific target populations.

Details

Language :
English
ISSN :
17448395 and 14760584
Volume :
18
Issue :
5
Database :
OpenAIRE
Journal :
Expert Review of Vaccines
Accession number :
edsair.doi.dedup.....8d0e212e0ef3bb0223c5dcb10c0f0e2f